Introducing Electronic Alerts to Reduce Inappropriate Digoxin Prescribing in Older Adults
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorConsorci Sanitari de l'Alt Penedès i Garraf
About this trial
The intervention consists of introducing computerized alerts into the electronic medical record of the CSAPG (MIRA software), which are triggered when a physician prescribes digoxin at a dose higher than the recommended amount (more than 0.125 mg/day).
The main objective of this study is to evaluate the effectiveness of a visible computerized alert aimed at physicians responsible for hospitalized elderly patients who have been prescribed digoxin at a dose higher than 0.125 mg/day (the recommended dose), in reducing the number of patients receiving inappropriate digoxin doses.
Eligibility criteria
Qualifiers
Men and women over 64 years of age.
Hospitalized in inpatient wards of the study centers during the study period.
Disqualifiers
Pacients under 64 years old
Patients without complete data available
Trial design
Treatments tested in this trial
- Digoxin alarm
Treatment groups
5,954 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov